Jessica Tassan
Stock Analyst at Piper Sandler
(1.72)
# 3,157
Out of 4,749 analysts
63
Total ratings
30%
Success rate
-9.57%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Reiterates: Overweight | $31 → $33 | $28.46 | +15.95% | 5 | Jan 29, 2025 | |
| HUM Humana | Maintains: Neutral | $270 → $288 | $293.23 | -1.78% | 3 | Jan 15, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $605 → $600 | $542.49 | +10.60% | 5 | Jan 2, 2025 | |
| TDOC Teladoc Health | Reiterates: Overweight | $11 → $13 | $10.16 | +27.95% | 5 | Dec 4, 2024 | |
| HCAT Health Catalyst | Reiterates: Overweight | $11 → $12 | $5.63 | +113.14% | 10 | Nov 26, 2024 | |
| CVS CVS Health | Maintains: Overweight | $72 → $64 | $56.48 | +13.31% | 4 | Nov 25, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $392 → $394 | $294.21 | +33.92% | 2 | Nov 5, 2024 | |
| OSCR Oscar Health | Reiterates: Overweight | $28 | $16.60 | +68.67% | 4 | Sep 10, 2024 | |
| MPLN MultiPlan | Reiterates: Neutral | $80 → $40 | $18.26 | +119.06% | 2 | Aug 7, 2024 | |
| ALHC Alignment Healthcare | Reiterates: Overweight | $8 → $10 | $15.39 | -35.02% | 4 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $24 → $22 | $22.66 | -2.91% | 4 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $15 | $6.89 | +117.71% | 4 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $23 | $59.10 | -61.08% | 3 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $44.99 | +55.59% | 4 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $100 → $70 | $10.78 | +549.35% | 2 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $33 | $10.45 | +215.79% | 2 | Nov 4, 2022 |
Phreesia
Jan 29, 2025
Reiterates: Overweight
Price Target: $31 → $33
Current: $28.46
Upside: +15.95%
Humana
Jan 15, 2025
Maintains: Neutral
Price Target: $270 → $288
Current: $293.23
Upside: -1.78%
UnitedHealth Group
Jan 2, 2025
Maintains: Overweight
Price Target: $605 → $600
Current: $542.49
Upside: +10.60%
Teladoc Health
Dec 4, 2024
Reiterates: Overweight
Price Target: $11 → $13
Current: $10.16
Upside: +27.95%
Health Catalyst
Nov 26, 2024
Reiterates: Overweight
Price Target: $11 → $12
Current: $5.63
Upside: +113.14%
CVS Health
Nov 25, 2024
Maintains: Overweight
Price Target: $72 → $64
Current: $56.48
Upside: +13.31%
The Cigna Group
Nov 5, 2024
Reiterates: Overweight
Price Target: $392 → $394
Current: $294.21
Upside: +33.92%
Oscar Health
Sep 10, 2024
Reiterates: Overweight
Price Target: $28
Current: $16.60
Upside: +68.67%
MultiPlan
Aug 7, 2024
Reiterates: Neutral
Price Target: $80 → $40
Current: $18.26
Upside: +119.06%
Alignment Healthcare
Aug 6, 2024
Reiterates: Overweight
Price Target: $8 → $10
Current: $15.39
Upside: -35.02%
May 8, 2024
Maintains: Neutral
Price Target: $24 → $22
Current: $22.66
Upside: -2.91%
Jan 9, 2024
Maintains: Overweight
Price Target: $12 → $15
Current: $6.89
Upside: +117.71%
Nov 10, 2023
Maintains: Neutral
Price Target: $21 → $23
Current: $59.10
Upside: -61.08%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $44.99
Upside: +55.59%
Feb 27, 2023
Downgrades: Neutral
Price Target: $100 → $70
Current: $10.78
Upside: +549.35%
Nov 4, 2022
Maintains: Overweight
Price Target: $40 → $33
Current: $10.45
Upside: +215.79%